000			01983 a2200517 4500
005			20250515090458.0
264		0	_c20080117
008			200801s 0 0 eng d
022			_a0014-4886
024	7		_a10.1016/j.expneurol.2007.07.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aMorgese, Maria Grazia
245	0	0	_aAnti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. _h[electronic resource]
260			_bExperimental neurology _cNov 2007
300			_a110-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAmidohydrolases _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xadverse effects
650	0	4	_aArachidonic Acids _xmetabolism
650	0	4	_aBasal Ganglia _xmetabolism
650	0	4	_aBenzamides _xtherapeutic use
650	0	4	_aBenzoxazines _xtherapeutic use
650	0	4	_aCannabinoids _xagonists
650	0	4	_aCapsaicin _xanalogs & derivatives
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDyskinesia, Drug-Induced _xmetabolism
650	0	4	_aEndocannabinoids
650	0	4	_aLevodopa _xadverse effects
650	0	4	_aMale
650	0	4	_aMorpholines _xtherapeutic use
650	0	4	_aNaphthalenes _xtherapeutic use
650	0	4	_aOxidopamine
650	0	4	_aParkinson Disease, Secondary _xchemically induced
650	0	4	_aPolyunsaturated Alkamides _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptor, Cannabinoid, CB1 _xdrug effects
650	0	4	_aTRPV Cation Channels _xantagonists & inhibitors
700	1		_aCassano, Tommaso
700	1		_aCuomo, Vincenzo
700	1		_aGiuffrida, Andrea
773	0		_tExperimental neurology _gvol. 208 _gno. 1 _gp. 110-9
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2007.07.021 _zAvailable from publisher's website
999			_c17422849 _d17422849